FOCUS
Swixx BioPharma’s GEOGRAPHIC, STRATEGIC AND THERAPEUTIC FOCUS Swixx BioPharma has been historically focused on Europe’s CEE region plus Greece. Recently, we have also entered into Central Asia, with subsidiaries in Kazakhstan and Uzbekistan. We intend in 2023 onwards to enter Latin America, Middle East or Africa. Swixx’s long term ambition is to offer our clients a multiple-region, “Rest of World” single-stop solution outside of the top 20 global pharmaceutical markets. Swixx BioPharma’s focus is in the following strategic and therapeutic areas: Modern, high tech, professionally-positioned products with a compelling medical proposition (evidence based medicine / significant clinical impact) Rx business split into 4 Business units, launching highly innovative, new therapies: o Rare disease / orphan medicines o Hematology/Oncology o Innovative Specialty Care o Vaccines Swixx also commercializes multiple Consumer Healthcare products via a dedicated CHC BU in a limited territory - the Baltics, W. Balkans and Russia only The company is interested to purchase complementary existing brands, licenses or platforms that are not in conflict with our existing our partners portfolios
Swixx BioPharma has been historically focused on the CEE region but is now swiftly expanding into other geographies, now incluging: Albania, Bosnia and Herzegovina, Belarus, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Kazakhstan, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Uzbekistan CEE region comprise 275 million people and a pharmaceutical market of 50+ billion Euros. Their economies currently are amongst the least developed in Europe, but they show considerable promise and boast well-educated and cultured people. Many western healthcare companies chose not to enter these markets, but nonetheless wish to have their products present and represented by a professional, compliant and competent regional partner. Swixx BioPharma aims to fill this need and to bring modern medicines to the people of the region.
A Swiss-based Pharmaceutical Company
© 2019 Swixx Biopharma SA. All rights reserved. Terms of Use. Privacy Policy. PV Data Privacy. Cookie Policy.